168 related articles for article (PubMed ID: 37515053)
1. Attitude and Acceptance towards COVID-19 Booster Doses among Literacy Advantaged Population in Pakistan: A Cross-Sectional Study.
Ahmad M; Sattar A; Aroosa S; Majeed A; Rasheed MA; Ahmad W; Iqbal A; Omer MO; Beg BM; Mushtaq RMZ
Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515053
[TBL] [Abstract][Full Text] [Related]
2. Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.
Qin C; Yan W; Du M; Liu Q; Tao L; Liu M; Liu J
Front Public Health; 2022; 10():986916. PubMed ID: 36589991
[TBL] [Abstract][Full Text] [Related]
3. Sequential viral introductions and spread of BA.1 across Pakistan provinces during the Omicron wave.
Bukhari AR; Ashraf J; Kanji A; Rahman YA; Trovão NS; Thielen PM; Yameen M; Kanwar S; Khan W; Kabir F; Nisar MI; Merritt B; Hasan R; Spiro D; Rasmussen Z; Aamir UB; Hasan Z
BMC Genomics; 2023 Aug; 24(1):432. PubMed ID: 37532989
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccine acceptance and hesitancy among the general population of Pakistan: a population-based survey.
Soomar SM; Soomar SM; Khan M; Moin G; Azam I
BMJ Open; 2022 Sep; 12(9):e064096. PubMed ID: 36115670
[TBL] [Abstract][Full Text] [Related]
5. Demographics of Cystic Echinococcosis Patients Treated Surgically in Lahore, Pakistan: A Single Centre Study from 2007 - 2018.
Rasib Q; Khan A; Ahmed H; Nizamuddin S; Asif F; Afzal MS; Simsek S; Khurshid F; Irum S; Hussain N; Riaz S; Khan SS; Budke CM
Helminthologia; 2021 Jun; 58(2):162-172. PubMed ID: 34248376
[TBL] [Abstract][Full Text] [Related]
6. Will People Accept a Third Booster Dose of the COVID-19 Vaccine? A Cross-Sectional Study in China.
Sun Y; Dai H; Wang P; Zhang X; Cui D; Huang Y; Zhang J; Xiang T
Front Public Health; 2022; 10():914950. PubMed ID: 35903387
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi.
Al Kaabi N; Yang Y; Eldin Hussein S; Yang T; Abdalla J; Wang H; Lou Z; Chinese Center For Disease Control And Prevention ; Bakkour A; Arafat A; China National Biotec Group Company Limited ; Jiang Z; Tian Y; National Engineering Technology Research Center For Combined Vaccines Wuhan Institute Of Biological Products Co Ltd ; Beijing Institute Of Biological Products Company Limited ; Xiao P; Zaher W; Eltantawy I; Wang C; Xu G; Zhang Y; Yang X
Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851177
[TBL] [Abstract][Full Text] [Related]
8. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
[TBL] [Abstract][Full Text] [Related]
9. Multi-dimensional potential factors influencing COVID-19 vaccine booster acceptance and hesitancy among university academic community in Bangladesh: A cross-sectional comparative study.
Roy DN; Azam MS; Islam E
PLoS One; 2023; 18(4):e0281395. PubMed ID: 37053270
[TBL] [Abstract][Full Text] [Related]
10. Parents' willingness to vaccinate themselves and their children with the booster vaccine against SARS-CoV-2: A cross-sectional study in Puyang city, China.
Zhou Y; Li GX; Zhao TS; Du J; Zhang WX; Xie MZ; Chen LY; Zeng J; Wang C; Liu B; Liu YQ; Cui F; Lu QB
J Med Virol; 2023 Jan; 95(1):e28256. PubMed ID: 36305477
[TBL] [Abstract][Full Text] [Related]
11. Trajectory of COVID-19 vaccine hesitancy post-vaccination and public's intention to take booster vaccines: A cross-sectional analysis.
Salman M; Mallhi TH; Khan YH; Mustafa ZU; Khan MT; Khan FU; Butt MH; Shehzadi N; Farrukh MJ; Waheed M; Azmat F; Saeed A; Mazhar SA; Ali A; Ashfaq A; Hussain K
Hum Vaccin Immunother; 2023 Aug; 19(2):2225990. PubMed ID: 37350298
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
[TBL] [Abstract][Full Text] [Related]
13. The Impact of COVID-19 on the Psychological Well-Being of Surgeons in Pakistan: A Multicenter Cross-Sectional Study.
Zeeshan S; Rajab Ali M; Khan RN; Allana AR; Zahid N; Najjad MK; Abro AA; Nadeem MA; Mughal Z; Ahmed I; Ali A
Cureus; 2022 Jul; 14(7):e26997. PubMed ID: 35989806
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
[TBL] [Abstract][Full Text] [Related]
15. "Sehat Sahulat Program": A Leap into the Universal Health Coverage in Pakistan.
Hasan SS; Mustafa ZU; Kow CS; Merchant HA
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742247
[TBL] [Abstract][Full Text] [Related]
16. Role of meteorological parameters with the spread of Covid-19 in Pakistan: application of autoregressive distributed lag approach.
Ul Haq Z; Mehmood U; Tariq S; Hanif A; Nawaz H
Int J Environ Sci Technol (Tehran); 2023 Jun; ():1-22. PubMed ID: 37360555
[TBL] [Abstract][Full Text] [Related]
17. Knowledge, Attitudes, and Practices of Adult Iraqi Population Towards COVID-19 Booster Dose: A Cross-Sectional Study.
Al-Qerem W; Jarab A; Hammad A; Alsajri AH; Al-Hishma SW; Ling J; Alabdullah AS; Salama A; Mosleh R
Patient Prefer Adherence; 2022; 16():1525-1537. PubMed ID: 35769339
[TBL] [Abstract][Full Text] [Related]
18. Acceptance of COVID-19 booster vaccination based on the protection motivation theory: A cross-sectional study in China.
Wu F; Yuan Y; Deng Z; Yin D; Shen Q; Zeng J; Xie Y; Xu M; Yang M; Jiang S; Zhang C; Lu H; Sun C
J Med Virol; 2022 Sep; 94(9):4115-4124. PubMed ID: 35506329
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study.
Lounis M; Bencherit D; Rais MA; Riad A
Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455371
[TBL] [Abstract][Full Text] [Related]
20. Willingness and Perceptions Regarding COVID-19 Vaccine Booster Dose in Pakistani Vaccinated Population: A Cross-Sectional Survey.
Moeed A; Najeeb H; Saleem A; Asghar MS; Rafi HM; Khattak AK; Bilal Z; Seboka BT
Front Public Health; 2022; 10():911518. PubMed ID: 35844859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
